使用nullclines来平衡治疗疗效和神经毒性,以持续控制瘤
Lois C Okereke1, Ernesto A B F Lima2, Anna G Sorace3
1Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin, Austin, Texas 78712, USA.
Mathematical biosciences
|September 12, 2025
概括
这项研究开发了数学模型,以使用个性化的低剂量药物疗法保持瘤大小在界限内,显著降低药物度和毒性,同时稳定疾病.
科学领域:
- 数学瘤学数学瘤学
- 系统生物学 系统生物学
- 药理动力学是什么 药理动力学
背景情况:
- 越来越多的人对针对癌症治疗的个性化治疗方案感兴趣.
- 需要制定策略,在特定的范围内保持瘤负担,同时尽量减少药物毒性.
- 瘤异质性和药物递送动态对治疗优化构成挑战.
研究的目的:
- 开发和分析瘤生长,细胞毒药物效应和神经毒性的数学模型.
- 确定有效的剂量范围,以稳定瘤负担并减轻神经毒性.
- 为个性化,低剂量癌症治疗提供理论框架.
主要方法:
- 结合的普通微分方程系统 (ODEs) 建模瘤负担,药物效应和神经毒性.
- 分析nullclines以确定有效剂量范围以稳定瘤.
- 使用乳腺癌数据验证治疗方案的in silico实验.
主要成果:
- 努尔克林分析产生了有限的治疗方案,以稳定瘤负担.
- 与根除方案相比,瘤制 (RECIST) 降低了高达51.8%的药物度.
- 在 silico 试验中,表现出稳定的疾病维持与受控的神经毒性.
结论:
- 数学建模可以指导个性化癌症治疗的设计,平衡有效性和毒性.
- 低剂量,稳定治疗方案可以有效地控制瘤生长并改善生活质量.
- 定量生物指数可以为癌症患者的个性化治疗策略提供信息.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K